In 2024, Canada's blood and blood-forming organs medicine sales are predicted to reach 1.8 billion CAD, an increase from 2023. The forecasted sales depict a steady growth trend, reaching 2.12 billion CAD by 2028. From 2024 to 2028, the market is projected to experience a consistent year-on-year growth of approximately 4.2%. This upward trajectory reflects a compound annual growth rate (CAGR) of about 3.9% over the five-year forecast period.
Future trends to consider include:
- Increasing demand for advanced therapies in hematology.
- The potential impact of new pharmaceutical entrants and innovations.
- Evolving healthcare policies and their influence on the market dynamics.
- Growth in personalized medicine approaches, steering treatment methodologies.
